Your search returned 6 results.

Results
	1.	Increasing national trend of direct-acting antiviral discontinuation among people treated for HCV 2016–2021 by Carson J Barbieri S Matthews G Dore G Hajarizadeh B Series: Hepatology Communications ; Vol. 7 (4)Alphen aan den Rijn Wolters Kluwer Health Inc. 2023 Online resources: Click here to access online Availability: Items available for loan: Library (1).
	2.	Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis by Cunningham E B Wheeler A Hajarizadeh B et al Series: The Lancet Gastroenterology and Hepatology ; Vol 7 (5)London Elsevier 2022 Online resources: Click here to access online Availability: Items available for loan: Library (1).
	3.	Timely hepatitis C RNA testing and treatment in the era of direct-acting antiviral therapy among people with hepatitis C in New South Wales, Australia by Yousafzai M T Alavi M Valerio H Hajarizadeh B Grebely J Dore G J Series: Viruses ; Vol.14 (7) Basel Swi. MDPI 2022 Online resources: Click here to access online Availability: Items available for loan: Library (1).
	4.	Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study by Hajarizadeh B Grebely J Byrne M et al Series: The Lancet Gastroenterology and Hepatology ; Vol 6 no. 7London Lancet 2021 Online resources: Click here to access online Availability: Items available for loan: Library (1).
	5.	Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis by Hajarizadeh B Cunningham E Reid H et al Series: Lancet \| ; 3 (11)London Elsevier 2018 Online resources: Click here to access online Availability: Items available for loan: Library (1)Call number: 3.1.
	6.	Findings of the Charting Health Impacts (CHI) Study by Hajarizadeh B Pitts M McNally S Wallace J Melbourne ARCSHS 2014 Online resources: Download the report Availability: Items available for loan: Library (1)Call number: 0.4.